Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma

Lung squamous cell carcinoma (LUSC) is the second major type of lung cancer globally. The majority of patients with LUSC are clinically diagnosed at the advanced stages, thus it is urgent to identify suitable prognostic markers for LUSC. B-cell lymphoma 2 (Bcl-2) has been widely studied in non-small...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Changjiang, Wu, Jiaqi, Yang, Fan, Qiu, Mangtang, Hu, Shuofeng, Guo, Saisai, Wu, Jin, Ying, Xiaomin, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920356/
https://www.ncbi.nlm.nih.gov/pubmed/29725421
http://dx.doi.org/10.3892/ol.2018.8198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920356/
https://www.ncbi.nlm.nih.gov/pubmed/29725421
http://dx.doi.org/10.3892/ol.2018.8198

Ejemplares similares